Senior Vice President, Chief Medical and Scientific Officer · Medtronic plc (MDT)

Richard Kuntz

FY2021 is the first fiscal year CompBrief holds for Richard Kuntz as a named executive officer of Medtronic; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$6,417,946

Salary $850,986Stock awards $2,240,138

7th of 7 named executive officers at Medtronic by FY2021 total.

7 named officers on file for Medtronic, FY2021

Richard Kuntz’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • MDT’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Medtronic’s whole pay program stands against its peers

  • Medtronic’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MDT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed August 27, 2021 (DEF 14A).

Free

Get Richard Kuntz’s full pay file as a PDF — free

More than this page: up to 10 years of Richard’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Richard Kuntz compensation by year

Medtronic Summary Compensation Table · the one fiscal year held
In US dollars, as Medtronic reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$850,986
Bonus$0
Stock awards$2,240,138
Option awards$1,565,006
Non-equity incentive$1,677,548
Pension and deferred compensation$0
All other$84,269
Total$6,417,946

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Medtronic plc DEF 14A filed August 27, 2021, accession 0001193125-21-259369, and prior-year filings.

How this page was built: the Medtronic plc filed document, accession 0001193125-21-259369. Every figure is read from that document and cited to the page and table it appears in. Filed August 27, 2021.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU14,865$1,936,166—
PSU10,702$1,393,936—
PSU10,701$1,393,805—
PSU6,398$833,340—
Option298—$83.97
Option10,322—$83.97
Option30,502—$89.08
Option51,676—$103.26
Option1,212—$103.26
Option848—$89.08
Option60,453—$97.33
Option36,524—$97.33

Per the Outstanding Equity Awards at Fiscal Year-End table in Medtronic plc's FY2021 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 13 award rows shown.

Medtronic’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Geoffrey MarthaChairman and Chief Executive Officer$16,471,648
Karen ParkhillExecutive Vice President and Chief Financial Officer$8,516,817
Omar IshrakFormer Executive Chairman and Chief Executive Officer$8,348,288
Michael CoyleFormer Executive Vice President and Group President, CVG$8,224,960
Bradley LermanFormer Senior Vice President, General Counsel and Secretary$7,422,842
Robert WhiteExecutive Vice President, Medical Surgical Portfolio$6,921,151
Richard Kuntz · this pageSenior Vice President, Chief Medical and Scientific Officer$6,417,946

The full Medtronic compensation record

free company brief

This page is one person within Medtronic's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Medtronic proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Medtronic's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Kuntz's compensation dossier · One-time report. No refunds.